In murine PDAC models, oncolytic viruses have demonstrated the capacity to reduce tumor burden and prolong survival by downregulating TAMs and increasing infiltration and function of Th1 CD4+ cells and CD8+ T cells [149,150]. This evidence concerns the gene CD8A and neoplasm.